FDA Calendar

Company Name Repligen Corp
Drug Name SecreFlo (NDA)
Event Name FDA panel to review SecreFlo for detection of pancreatic duct abnormalities
Event Date 05/31/2012
Outcome Date
Outcome FDA Advisory Committee meeting cancelled; Complete response letter expected
Drug Status
Rival Drugs
Market Potential
Other Approvals
Repligen Announces FDA Advisory Committee Date For SecreFlo NDA
Repligen - Eyeing Sustainable Profitability
Revisiting Repligen...
Repligen Says FDA Cancels Advisory Committee Meeting
Return to FDA Calendar